Dietary patterns modulate the risk of non-alcoholic fatty liver disease in Chinese adults

Nutrients

Volumn 7, Issue 6, 2015, Pages 4778-4791

  Yang, Chao Qun ^a   Shu, Long ^b   Wang, Shuai ^a   Wang, Jia Jia ^a   Zhou, Yu ^a   Xuan, Yu Jie ^a   Wang, Su Fang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ZHEJIANG HOSPITAL   (China)

Author keywords

China; Dietary patterns; Factor analysis; Non alcoholic fatty liver Disease

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ABDOMINAL OBESITY; ADULT; ALCOHOL CONSUMPTION; ANIMAL DIET; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHINA; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET; DIETARY INTAKE; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PREVALENCE; RISK ASSESSMENT; SCORING SYSTEM; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; FOOD GRAIN; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITIONAL ASSESSMENT; QUESTIONNAIRE; RISK FACTOR; VEGETABLE; WAIST CIRCUMFERENCE;

ANIMALIA;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY HEIGHT; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; DIET; EDIBLE GRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITION ASSESSMENT; PREVALENCE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; VEGETABLES; WAIST CIRCUMFERENCE;

EID: 84934923404     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7064778     Document Type: Article

References (44)

1. Colak, Y.; Tuncer, I.; Senates, E.; Ozturk, O.; Doganay, L.; Yilmaz, Y. Nonalcoholic fatty liver disease: A nutritional approach. Metab. Syndr. Relat. Disord. 2012, 10, 161–166.
2. Hou, X.H.; Zhu, Y.X.; Lu, H.J.; Chen, H.F.; Li, Q.; Jiang, S.; Xiang, K.S.; Jia, W.P. Non-alcoholic fatty liver disease’s prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the chinese. J. Gastroenterol. Hepatol. 2011, 26, 722–730.
3. Lin, Y.C.; Chang, P.F.; Chang, M.H.; Ni, Y.H. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. Am. J. Clin. Nutr. 2014, 99, 869–874.
4. McCarthy, E.M.; Rinella, M.E. The role of diet and nutrient composition in nonalcoholic fatty liver disease. J. Acad. Nutr. Diet. 2012, 112, 401–409.
5. Vernon, G.; Baranova, A.; Younossi, Z.M. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011, 34, 274–285.
6. Lonardo, A.; Ballestri, S.; Marchesini, G.; Angulo, P.; Loria, P. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Dig. Liver Dis. 2015, 47, 181–190.
7. Machado, M.V.; Cortez-Pinto, H. Management of fatty liver disease with the metabolic syndrome. Expert Rev. Gastroenterol. Hepatol. 2014, 8, 487–500.
8. Di Minno, M.N.; Russolillo, A.; Lupoli, R.; Ambrosino, P.; Di Minno, A.; Tarantino, G. Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J. Gastroenterol. 2012, 18, 5839–5847.
9. Mouzaki, M.; Allard, J.P. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 2012, 46, 457–467.
10. Cortez-Pinto, H.; Jesus, L.; Barros, H.; Lopes, C.; Moura, M.C.; Camilo, M.E. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin. Nutr. 2006, 25, 816–823.
11. Schulze, M.B.; Hoffmann, K. Methodological approaches to study dietary patterns in relation to risk of coronary heart disease and stroke. Br. J. Nutr. 2006, 95, 860–869.
12. Cortez-Pinto, H.; Machado, M. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease. Expert Rev. Gastroenterol. Hepatol. 2008, 2, 217–231.
13. Carvalhana, S.; Machado, M.V.; Cortez-Pinto, H. Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 468–473.
14. Abenavoli, L.; Milic, N.; Peta, V.; Alfieri, F.; De Lorenzo, A.; Bellentani, S. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World J. Gastroenterol. 2014, 20, 16831–16840.
15. Wang, D.; He, Y.; Li, Y.; Luan, D.; Yang, X.; Zhai, F.; Ma, G. Dietary patterns and hypertension among chinese adults: A nationally representative cross-sectional study. BMC Public Health 2011, 11, 925.
16. Esmaillzadeh, A.; Kimiagar, M.; Mehrabi, Y.; Azadbakht, L.; Hu, F.B.; Willett, W.C. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am. J. Clin. Nutr. 2007, 85, 910–918.
17. Berg, C.M.; Lappas, G.; Strandhagen, E.; Wolk, A.; Toren, K.; Rosengren, A.; Aires, N.; Thelle, D.S.; Lissner, L. Food patterns and cardiovascular disease risk factors: The swedish intergene research program. Am. J. Clin. Nutr. 2008, 88, 289–297.
18. Zuo, H.; Shi, Z.; Yuan, B.; Dai, Y.; Hu, G.; Wu, G.; Hussain, A. Interaction between physical activity and sleep duration in relation to insulin resistance among non-diabetic Chinese adults. BMC Public Health 2012, 12, 247.
19. Chobanian, A.V.; Bakris, G.L.; Black, H.R.; Cushman, W.C.; Green, L.A.; Izzo, J.L.; Jones, D.W.; Materson, B.J.; Oparil, S.; Wright, J.T. et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42, 1206–1252.
20. Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.; Loria, C.M.; Smith, S.C. et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640–1645.
21. Nascimbeni, F.; Pais, R.; Bellentani, S.; Day, C.P.; Ratziu, V.; Loria, P.; Lonardo, A. From nafld in clinical practice to answers from guidelines. J. Hepatol. 2013, 59, 859–871.
22. Zhang, C.; Schulze, M.B.; Solomon, C.G.; Hu, F.B. A prospective study of dietary patterns, meat intake and the risk of gestational diabetes mellitus. Diabetologia 2006, 49, 2604–2613.
23. Newby, P.K.; Tucker, K.L. Empirically derived eating patterns using factor or cluster analysis: A review. Nutr. Rev. 2004, 62, 177–203.
24. Hudgins, L.C.; Hellerstein, M.; Seidman, C.; Neese, R.; Diakun, J.; Hirsch, J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J. Clin. Investig. 1996, 97, 2081–2091.
25. Mager, D.R.; Patterson, C.; So, S.; Rogenstein, C.D.; Wykes, L.J.; Roberts, E.A. Dietary and physical activity patterns in children with fatty liver. Eur. J. Clin. Nutr. 2010, 64, 628–635.
26. Ouyang, X.; Cirillo, P.; Sautin, Y.; McCall, S.; Bruchette, J.L.; Diehl, A.M.; Johnson, R.J.; Abdelmalek, M.F. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 2008, 48, 993–999.
27. York, L.W.; Puthalapattu, S.; Wu, G.Y. Nonalcoholic fatty liver disease and low-carbohydrate diets. Annu. Rev. Nutr. 2009, 29, 365–379.
28. Villaca Chaves, G.; Pereira, S.E.; Saboya, C.J.; Ramalho, A. Non-alcoholic fatty liver disease and its relationship with the nutritional status of vitamin a in individuals with class III obesity. Obes. Surg. 2008, 18, 378–385.
29. Harrison, S.A.; Torgerson, S.; Hayashi, P.; Ward, J.; Schenker, S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 2003, 98, 2485–2490.
30. Foster, T.; Budoff, M.J.; Saab, S.; Ahmadi, N.; Gordon, C.; Guerci, A.D. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: The St francis heart study randomized clinical trial. Am. J. Gastroenterol. 2011, 106, 71–77.
31. Arendt, B.M.; Allard, J.P. Effect of atorvastatin, vitamin e and c on nonalcoholic fatty liver disease: Is the combination required? Am. J. Gastroenterol. 2011, 106, 78–80.
32. Musso, G.; Gambino, R.; De Michieli, F.; Cassader, M.; Rizzetto, M.; Durazzo, M.; Faga, E.; Silli, B.; Pagano, G. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003, 37, 909–916.
33. Vallim, T.; Salter, A.M. Regulation of hepatic gene expression by saturated fatty acids. Prostaglandins Leukot. Essent. Fat. Acids 2010, 82, 211–218.
34. Abid, A.; Taha, O.; Nseir, W.; Farah, R.; Grosovski, M.; Assy, N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J. Hepatol. 2009, 51, 918–924.
35. Nseir, W.; Nassar, F.; Assy, N. Soft drinks consumption and nonalcoholic fatty liver disease. World J. Gastroenterol. 2010, 16, 2579–2588.
36. Pereira, M.A.; Kartashov, A.I.; Ebbeling, C.B.; Van Horn, L.; Slattery, M.L.; Jacobs, D.R.; Ludwig, D.S. Fast-food habits, weight gain, and insulin resistance (the cardia study): 15-year prospective analysis. Lancet 2005, 365, 36–42.
37. Marchesini, G.; Brizi, M.; Morselli-Labate, A.M.; Bianchi, G.; Bugianesi, E.; McCullough, A.J.; Forlani, G.; Melchionda, N. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 1999, 107, 450–455.
38. Kris-Etherton, P.M.; Pearson, T.A.; Wan, Y.; Hargrove, R.L.; Moriarty, K.; Fishell, V.; Etherton, T.D. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am. J. Clin. Nutr. 1999, 70, 1009–1015.
39. Shapiro, H.; Tehilla, M.; Attal-Singer, J.; Bruck, R.; Luzzatti, R.; Singer, P. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin. Nutr. 2011, 30, 6–19.
40. Tanaka, N.; Sano, K.; Horiuchi, A.; Tanaka, E.; Kiyosawa, K.; Aoyama, T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2008, 42, 413–418.
41. Capanni, M.; Calella, F.; Biagini, M.R.; Genise, S.; Raimondi, L.; Bedogni, G.; Svegliati-Baroni, G.; Sofi, F.; Milani, S.; Abbate, R.; et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: A pilot study. Aliment. Pharmacol. Ther. 2006, 23, 1143–1151.
42. Ogihara, T.; Asano, T.; Fujita, T. Contribution of salt intake to insulin resistance associated with hypertension. Life Sci. 2003, 73, 509–523.
43. Lastra, G.; Dhuper, S.; Johnson, M.S.; Sowers, J.R. Salt, aldosterone, and insulin resistance: Impact on the cardiovascular system. Nat. Rev. Cardiol. 2010, 7, 577–584.
44. Hu, F.B. Dietary pattern analysis: A new direction in nutritional epidemiology. Curr. Opin. Lipidol. 2002, 13, 3–9.